<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vollmers S</submitter><funding>NIAID NIH HHS</funding><pagination>922252</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9334850</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>NK cells play a pivotal role in viral immunity, utilizing a large array of activating and inhibitory receptors to identify and eliminate virus-infected cells. Killer-cell immunoglobulin-like receptors (KIRs) represent a highly polymorphic receptor family, regulating NK cell activity and determining the ability to recognize target cells. Human leukocyte antigen (HLA) class I molecules serve as the primary ligand for KIRs. Herein, HLA-C stands out as being the dominant ligand for the majority of KIRs. Accumulating evidence indicated that interactions between HLA-C and its inhibitory KIR2DL receptors (KIR2DL1/L2/L3) can drive HIV-1-mediated immune evasion and thus may contribute to the intrinsic control of HIV-1 infection. Of particular interest in this context is the recent observation that HIV-1 is able to adapt to host &lt;i>HLA-C&lt;/i> genotypes through Vpu-mediated downmodulation of HLA-C. However, our understanding of the complex interplay between &lt;i>KIR/HLA&lt;/i> immunogenetics, NK cell-mediated immune pressure and HIV-1 immune escape is still limited. Therefore, we investigated the impact of specific &lt;i>KIR/HLA-C&lt;/i> combinations on the NK cell receptor repertoire and HIV-1 Vpu protein sequence variations of 122 viremic, untreated HIV-1&lt;sup>+&lt;/sup> individuals. Compared to 60 HIV-1&lt;sup>-&lt;/sup> controls, HIV-1 infection was associated with significant changes within the NK cell receptor repertoire, including reduced percentages of NK cells expressing NKG2A, CD8, and KIR2DS4. In contrast, the NKG2C&lt;sup>+&lt;/sup> and KIR3DL2&lt;sup>+&lt;/sup> NK cell sub-populations from HIV-1&lt;sup>+&lt;/sup> individuals was enlarged compared to HIV-1&lt;sup>-&lt;/sup> controls. Stratification along &lt;i>KIR/HLA-C&lt;/i> genotypes revealed a genotype-dependent expansion of KIR2DL1&lt;sup>+&lt;/sup> NK cells that was ultimately associated with increased binding affinities between KIR2DL1 and HLA-C allotypes. Lastly, our data hinted to a preferential selection of Vpu sequence variants that were associated with HLA-C downmodulation in individuals with high KIR2DL/HLA-C binding affinities. Altogether, our study provides evidence that HIV-1-associated changes in the KIR repertoire of NK cells are to some extent predetermined by host &lt;i>KIR2DL/HLA-C&lt;/i> genotypes. Furthermore, analysis of Vpu sequence polymorphisms indicates that differential KIR2DL/HLA-C binding affinities may serve as an additional mechanism how host genetics impact immune evasion by HIV-1.</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.</pubmed_title><pmcid>PMC9334850</pmcid><funding_grant_id>R01 AI158410</funding_grant_id><pubmed_authors>Wyen C</pubmed_authors><pubmed_authors>Korner C</pubmed_authors><pubmed_authors>Brias S</pubmed_authors><pubmed_authors>Schmidt AH</pubmed_authors><pubmed_authors>Hoelzemer A</pubmed_authors><pubmed_authors>Fittje P</pubmed_authors><pubmed_authors>Virdi S</pubmed_authors><pubmed_authors>Meurer A</pubmed_authors><pubmed_authors>Sauer G</pubmed_authors><pubmed_authors>Indenbirken D</pubmed_authors><pubmed_authors>Wolf E</pubmed_authors><pubmed_authors>Sauter J</pubmed_authors><pubmed_authors>Behrens GMN</pubmed_authors><pubmed_authors>Postel N</pubmed_authors><pubmed_authors>Vollmers S</pubmed_authors><pubmed_authors>Peine S</pubmed_authors><pubmed_authors>Richert L</pubmed_authors><pubmed_authors>Lehmann C</pubmed_authors><pubmed_authors>Roider J</pubmed_authors><pubmed_authors>Stephan C</pubmed_authors><pubmed_authors>Lobermeyer A</pubmed_authors><pubmed_authors>Trenkner T</pubmed_authors><pubmed_authors>Pauli R</pubmed_authors><pubmed_authors>Scholten S</pubmed_authors><pubmed_authors>Spinner CD</pubmed_authors><pubmed_authors>Altfeld M</pubmed_authors><pubmed_authors>Niehrs A</pubmed_authors><pubmed_authors>Nakel J</pubmed_authors><pubmed_authors>Norman PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.</name><description>NK cells play a pivotal role in viral immunity, utilizing a large array of activating and inhibitory receptors to identify and eliminate virus-infected cells. Killer-cell immunoglobulin-like receptors (KIRs) represent a highly polymorphic receptor family, regulating NK cell activity and determining the ability to recognize target cells. Human leukocyte antigen (HLA) class I molecules serve as the primary ligand for KIRs. Herein, HLA-C stands out as being the dominant ligand for the majority of KIRs. Accumulating evidence indicated that interactions between HLA-C and its inhibitory KIR2DL receptors (KIR2DL1/L2/L3) can drive HIV-1-mediated immune evasion and thus may contribute to the intrinsic control of HIV-1 infection. Of particular interest in this context is the recent observation that HIV-1 is able to adapt to host &lt;i>HLA-C&lt;/i> genotypes through Vpu-mediated downmodulation of HLA-C. However, our understanding of the complex interplay between &lt;i>KIR/HLA&lt;/i> immunogenetics, NK cell-mediated immune pressure and HIV-1 immune escape is still limited. Therefore, we investigated the impact of specific &lt;i>KIR/HLA-C&lt;/i> combinations on the NK cell receptor repertoire and HIV-1 Vpu protein sequence variations of 122 viremic, untreated HIV-1&lt;sup>+&lt;/sup> individuals. Compared to 60 HIV-1&lt;sup>-&lt;/sup> controls, HIV-1 infection was associated with significant changes within the NK cell receptor repertoire, including reduced percentages of NK cells expressing NKG2A, CD8, and KIR2DS4. In contrast, the NKG2C&lt;sup>+&lt;/sup> and KIR3DL2&lt;sup>+&lt;/sup> NK cell sub-populations from HIV-1&lt;sup>+&lt;/sup> individuals was enlarged compared to HIV-1&lt;sup>-&lt;/sup> controls. Stratification along &lt;i>KIR/HLA-C&lt;/i> genotypes revealed a genotype-dependent expansion of KIR2DL1&lt;sup>+&lt;/sup> NK cells that was ultimately associated with increased binding affinities between KIR2DL1 and HLA-C allotypes. Lastly, our data hinted to a preferential selection of Vpu sequence variants that were associated with HLA-C downmodulation in individuals with high KIR2DL/HLA-C binding affinities. Altogether, our study provides evidence that HIV-1-associated changes in the KIR repertoire of NK cells are to some extent predetermined by host &lt;i>KIR2DL/HLA-C&lt;/i> genotypes. Furthermore, analysis of Vpu sequence polymorphisms indicates that differential KIR2DL/HLA-C binding affinities may serve as an additional mechanism how host genetics impact immune evasion by HIV-1.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2024-11-10T03:37:50.894Z</modification><creation>2024-11-10T03:37:50.894Z</creation></dates><accession>S-EPMC9334850</accession><cross_references><pubmed>35911762</pubmed><doi>10.3389/fimmu.2022.922252</doi></cross_references></HashMap>